These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21178064)

  • 1. Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT.
    Abikhzer G; Alabed YZ; Azoulay L; Assayag J; Rush C
    AJR Am J Roentgenol; 2011 Jan; 196(1):176-80. PubMed ID: 21178064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
    Abele JT; Fung CI
    Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of (18)F-FDG in the liver in hepatic steatosis.
    Keramida G; Potts J; Bush J; Verma S; Dizdarevic S; Peters AM
    AJR Am J Roentgenol; 2014 Sep; 203(3):643-8. PubMed ID: 25148170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
    Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
    Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDG PET/CT.
    Dostbil Z; Varoğlu E; Serdengeçti M; Kaya B; Onder H; Sari O
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):156-61. PubMed ID: 23177332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept.
    Bural GG; Torigian DA; Burke A; Houseni M; Alkhawaldeh K; Cucchiara A; Basu S; Alavi A
    Mol Imaging Biol; 2010 Jun; 12(3):233-9. PubMed ID: 19806406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic steatosis is associated with increased hepatic FDG uptake.
    Keramida G; Potts J; Bush J; Dizdarevic S; Peters AM
    Eur J Radiol; 2014 May; 83(5):751-5. PubMed ID: 24581596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships of body habitus and SUV indices with signal-to-noise ratio of hepatic (18)F-FDG PET.
    Keramida G; Dunford A; Siddique M; Cook GJ; Peters AM
    Eur J Radiol; 2016 May; 85(5):1012-5. PubMed ID: 27130064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies].
    Batallés SM; Villavicencio RL; Quaranta A; Burgos L; Trezzo S; Staffieri R; Pezzotto SM
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):26-32. PubMed ID: 23177341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of intrahepatic fat distribution determined by (18)F-FDG PET and CT.
    Keramida G; Hunter J; Dizdarevic S; Peters AM
    Ann Nucl Med; 2016 Apr; 30(3):200-6. PubMed ID: 26768891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
    Paquet N; Albert A; Foidart J; Hustinx R
    J Nucl Med; 2004 May; 45(5):784-8. PubMed ID: 15136627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
    Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
    Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
    Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
    J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the normal adrenal gland with 18F-FDG PET/CT.
    Bagheri B; Maurer AH; Cone L; Doss M; Adler L
    J Nucl Med; 2004 Aug; 45(8):1340-3. PubMed ID: 15299059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
    Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
    AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
    Lyons K; Seghers V; Sorensen JI; Zhang W; Paldino MJ; Krishnamurthy R; Rohren EM
    AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy.
    Jacene HA; Leboulleux S; Baba S; Chatzifotiadis D; Goudarzi B; Teytelbaum O; Horton KM; Kamel I; Macura KJ; Tsai HL; Kowalski J; Wahl RL
    J Nucl Med; 2009 Nov; 50(11):1760-9. PubMed ID: 19837757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.